ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Reinforcement of osteochondoral defects repair with leukocyte platelet-rich fibrin and bone marrow-derived mononuclear cells in a rabbit model.

ウサギモデルにおける白血球血小板リッチフィブリンと骨髄由来単核細胞による骨軟骨欠損修復の強化 (機械翻訳の邦題)

BMC musculoskeletal disorders2025Salem M, Rizk A, Mosbah E, et al.
研究デザインその他の原著論文
対象動物

記録の確認項目

研究デザイン
その他の原著論文
対象
動物
出版年
2025
出典
doi.org
抄録の表示
表示あり
出版状態
有効な記録
状態確認日
2026/08/17
収集日
2026/08/04
鮮度
確認期限内
確認段階
自動処理
記録状態
公開

日本語要約(機械生成)

骨軟骨欠損の自然治癒は線維軟骨組織を形成し正常な軟骨特性を欠くため、様々な治療法が検討されている。本研究では、ウサギの膝関節に作製した骨軟骨欠損に対し、白血球血小板リッチフィブリン(PRF)と骨髄由来単核細胞(BM-MNCs)を単独または併用で移植し、術後3、6、12週における再生組織を免疫組織化学的および遺伝子発現解析により評価した。その結果、併用群(D群)では肉眼的評価、顕微鏡的評価、コラーゲンII型およびアグリカンの遺伝子発現が他の群と比較して有意に高かった。免疫組織化学ではD群でコラーゲンII型の高発現が認められた。結論として、PRFとBM-MNCsの併用は骨軟骨欠損の修復を促進し、再生組織のコラーゲンII型とプロテオグリカン沈着を強化することが示された。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

Background: The spontaneous healing of the osteochondral defects leads to the formation of fibrous or fibrocartilage tissue that lack normal cartilage characteristics. Therefore, there are different methods were approved for the functional treatment of osteochondral defects including, microfracture osteochondral mosaicoplasty, autologous chondrocyte implantation, platelets-rich plasma (PRP), bone marrow-derived mononuclear cells (BM-MNCs), Mesenchymal stem cells (MSCs) and platelets-rich fibrin (PRF). The present study evaluate the regeneration of osteochondoral defects in rabbits using PRF and BM-MNCs through immunohistochemical (IHC) and gene expression of collagen type II and aggrecan in the regenerated tissue at 3, 6 and 12 weeks postoperative.Methods: A total of 48 adult male New Zealand white rabbits, aged 5-6 months and weighed 3.5 to 4.0 kg, were used in this study and divided into four experimental groups, where all animals received an osteochondral defect of a 4 mm diameter and 5 mm depth was made in the trochlear groove of the left stifle joints. The defects were left for spontaneous repair in group A. They were filled either with 1 cm3 of PRF in group B, 6000k of BM-MNCs in group C or a combination of 0.8 cm3 of PRF and BM-MNCs in group D.Results: Gross observation of the defect, based on the degree of defect repair, the integration to border zone and the appearance of the defect area, was significantly higher in group D than other experimental groups (P ≤ 0.05). Microscopical evaluation including surface architecture, tissue morphology, cell distribution and safranin O staining of the matrix was significantly higher in group D than other groups (P ≤ 0.05). IHC staining showed a high concentration of collagen type II in groups B and D respectively; a moderate to high amount in groups and a moderate amount in group A (2.0 ± 0.5). The relative gene expression showed a significant increase of collagen type II and aggrecan in group D compared to other groups at all-time points.Conclusions: The current study's findings show that when PRF and BMNCs are combined, osteochondral lesions mend more quickly, and the regenerated tissue has stronger collagen type II and proteoglycan deposition than when either substance is utilized alone. To gather proof of the positive benefits of the combination of PRF and BMNCs, more research on clinically afflicted cases is required. Also, Autologous PRF is capable of stimulating BMSC growth and has good biocompatibility and can aid in the restoration of cartilage and subchondral bone.

MeSH

AggrecansAnimalsBone Marrow TransplantationCartilage, ArticularCollagen Type IIDisease Models, AnimalLeukocytes, MononuclearMaleMesenchymal Stem Cell TransplantationPlatelet-Rich FibrinRabbitsWound Healing

DOI 10.1186/s12891-025-08952-x

PMID 40713617

原文・出典を見る →